Skip to content

Identification of Vocal Biomarkers to Monitor the Health of People With a Chronic Disease

Identification of Vocal Biomarkers to Monitor the Health of People With a Chronic Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04848623
Acronym
CoLive Voice
Enrollment
50000
Registered
2021-04-19
Start date
2021-06-26
Completion date
2031-05-01
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease

Keywords

vocal biomarker, digital biomarker, digital health, artificial intelligence, telemonitoring, medical devices, precision health digital biomarker

Brief summary

The CoLive Voice research project aims to identify vocal biomarkers of severe conditions and frequent health symptoms. The project is based on digital technologies and statistical algorithms. This is an international anonymous survey where vocal recordings are collected simultaneously with large validated clinical and epidemiological data, in the context of various chronic diseases or frequent health symptoms in the general population.

Detailed description

With the objective of using vocal biomarkers for diagnosis, risk prediction/stratification and remote monitoring of various clinical outcomes and symptoms, there is a major need to develop surveys where audio data and clinical, epidemiological and patient-reported outcomes data are collected simultaneously. The objectives of CoLive Voice are: * To launch an international anonymized survey where vocal recordings are associated with large validated clinical and epidemiological data, in the context of various chronic diseases or frequent health symptoms in the general population * To extract audio features and train supervised machine learning models to identify key candidate vocal biomarkers of the aforementioned chronic conditions or related symptoms. Participants will be recruited online and will complete the survey using a web application. They will first answer a detailed questionnaire on their health status and then do 5 different voice records: 1. read a 30 sec prespecified text (from the Human Rights Declaration), 2. sustain voicing the vowel /aaaaaa/ as long and as steady as they can at a comfortable loudness 3. cough 3 times 4. breath in and out deeply 3 times 5. Count from 1 to 20 at a normal speed Vocal records will be pre-processed and converted into features, meaning the most dominating and discriminating characteristics of a vocal signal. Following the selection of features, machine or deep learning algorithms will be trained to automatically predict or classify the clinical, medical or epidemiological outcomes of interest, from vocal features alone or in combination with other health-related data.

Interventions

None listed

Sponsors

Luxembourg Institute of Health
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adolescents and adults \> 15 years * With or without health conditions * From all countries

Exclusion criteria

* Children \< 15 years

Design outcomes

Primary

MeasureTime frameDescription
StressAt baselinePatient reported outcome

Secondary

MeasureTime frameDescription
FatigueAt baselinePatient reported outcome using the fatigue severity scale (FSS). Minimum value =1, max value = 7 ; 7 is the highest level of fatigue
HypertensionAt baselinePatient reported outcome
DiabetesAt baselinePatient reported outcome
MigraineAt baselinePatient reported outcome
Covid-19At baselinePatient reported outcome
Overall painAt baselinePatient reported outcome
Respiratory problemsAt baselinePatient reported outcome
Level of quality of lifeAt baselinePatient reported outcome

Countries

Luxembourg

Contacts

CONTACTAurelie Fischer, MSc
aurelie.fischer@lih.lu00352621328591
PRINCIPAL_INVESTIGATORGuy Fagherazzi, PhD

LIH

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026